Researchers have determined the 3D structure of the receptor that the hormone oxytocin binds to. The findings could aid drug development.
Tags: hormones oxytocin drug-development health-and-medicine
"These interim results are very encouraging," says Evan Anderson of a COVID-19 vaccine in a phase 1 clinical trial.
Tags: covid-19 vaccines drug-development clinical-trials featured health-and-medicine immune-systems
A compound from the American beautyberry boosts an antibiotic's activity against MRSA, research indicates.
Tags: antibiotics plants drug-resistance drug-development featured health-and-medicine mrsa
A new formula for ultrafast insulin could work in much less time than the current stuff, according to research with pigs.
Tags: diabetes insulin materials-science polymers drug-development featured health-and-medicine
A new synthetic antibody may prevent the coronavirus from causing infection by blocking attachment to a key enzyme. It shows promise in a study with mice.
Tags: covid-19 antibodies viruses drug-development infections health-and-medicine
New research on influenza suggests that "the right early-stage antiviral treatment can block transmission to others and, in the long run, may well save more lives."
Tags: influenza covid-19 viruses drug-development health-and-medicine medications
The antibody S309, first identified in a blood sample from a recovered SARS patient, inhibits the coronavirus that causes COVID-19, researchers report.
Tags: covid-19 antibodies sars viruses drug-development featured health-and-medicine
In a clinical trial testing the safety and efficacy of remdesivir, the antiviral drug shows promise in treating adults diagnosed with COVID-19.
Tags: covid-19 viruses drug-development clinical-trials health-and-medicine medications
Winter the llama is an unlikely ally in the search for an effective COVID-19 treatment. The latest advance is a synthetic antibody.
Tags: covid-19 antibodies viruses drug-development featured health-and-medicine
Page 1 of 7